Joy Zou

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma”.

Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma

Frontiers in Endocrinology(2021)10.3389/fendo.2020.587065

N/A

0.723DataRank · unranked

9 citations

Mohammad Al-Jundi, Jaydira Del Rivero, Abhishek Jha, Marianne Knue, Joy Zou +7 more

Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [177Lu]Lu-DOTA-TATE therapy

Frontiers in Endocrinology(2023)10.3389/fendo.2023.1275813

N/A

0.440DataRank · unranked

11 citations

Mohammad Al-Jundi, Sungyoung Auh, Abhishek Jha, Joy Zou, Inna Shamis +12 more

Phase II Study of 177 Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers

Journal of Clinical Oncology(2025)10.1200/jco-25-00791

N/A

0DataRank · unranked

13 citations

Jaydira Del Rivero, Jorge A. Carrasquillo, A. Jha, Joy Zou, Inna Shamis +15 more